Skip to main navigation Skip to search Skip to main content

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Translated title of the contribution: Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionEpidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Original languageUndefined/Unknown
Pages (from-to)749-755
Number of pages7
JournalBritish Journal of Cancer
Volume111
Issue number4
Publication statusPublished - 2014

Cite this